Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Stop losing users to messy layouts. Bad web design kills conversions. Bento Grid Design organises your value proposition before they bounce.
India's first-ever Artificial Intelligence Impact Summit is scheduled in New Delhi's Bharat Mandapam from February 16 to 20, bringing together global leaders, innovators and policymakers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results